{"schema_version":"secwatch.filing_event.v1","accession":"0000882095-25-000035","form_type":"8-K","ticker":"GILD","cik":"0000882095","company_name":"GILEAD SCIENCES, INC.","filed_at":"2025-08-14T23:59:59+00:00","discovered_at":"2026-05-14T18:02:46.566313+00:00","generated_at":"2026-05-17T13:47:19.983916+00:00","sec_items":["5.02"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.4,"calibrated_materiality_score":0.4,"confidence":"high","headline":"Gilead names Erin Burkhart as SVP, Controllership and principal accounting officer","bullets":["Erin Burkhart, formerly Group VP and CAO at BioMarin, appointed effective September 22, 2025.","Burkhart succeeds Diane E. Wilfong, who steps down as interim Controller and principal accounting officer on the same date.","Burkhart previously held accounting/finance roles at Eli Lilly and began career at Arthur Andersen and Deloitte."],"urls":{"canonical":"https://secwatch.observer/filing/0000882095-25-000035","json":"https://secwatch.observer/filing/0000882095-25-000035.json","markdown":"https://secwatch.observer/filing/0000882095-25-000035.md","text":"https://secwatch.observer/filing/0000882095-25-000035.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/882095/000088209525000035/0000882095-25-000035-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/882095/000088209525000035/gild-20250810.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T13:47:19.983916+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}